newsfilter
← Latest News
GlobeNewswire·

MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance

ROCKVILLE, Md., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization